SecBot SecBot
8-K ·Filed May 5, 2026

XRAY

DENTSPLY SIRONA Inc.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago SEC0000818479-26-000147
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The maintained full-year guidance provides a floor for expectations, but the constant currency revenue decline and margin compression indicate the turnaround is still early. Watch for Q2 results to see if the restructuring plan gains traction; any downward guidance revision would be severe.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Dentsply Sirona reported Q1 2026 adjusted EPS of $0.27, roughly in line with the $0.28 consensus (a slight miss), while revenue of $880M was flat YoY but constant currency sales fell 6.7%. GAAP results worsened to a net loss of $10M vs income of $20M last year, and adjusted EBITDA dropped 23% YoY. The company reiterated its full-year 2026 guidance, which tempers the negative read, but underlying trends remain weak with declining margins and ongoing restructuring charges.

Key Financial Metrics

EPS
$0.27
est $0.28 · -3.6%
Revenue
$880.0M
+0.1% YoY
Rating
miss
Guidance
$3.5B-$3.6B
maintained
Free Cash Flow
-$12.0M
Gross Margin
48.5%

Key Facts

  • Adjusted EPS of $0.27 vs $0.28 consensus (miss of ~3.6%)
  • Revenue of $880M, +0.1% YoY reported, but constant currency down 6.7%
  • GAAP net loss of $10M vs net income of $20M in Q1 2025
  • Adjusted EBITDA fell 22.8% to $129M, margin down 430bps to 14.7%
  • Full-year 2026 outlook maintained: net sales $3.5B-$3.6B, adjusted EPS $1.40-$1.50
  • Restructuring costs of $67M in Q1 2026 (vs $9M in Q1 2025) weighed on results
  • Cash flow from operations improved to $40M vs $7M a year ago, but FCF remained negative at ($12M)

Financial Impact

Adjusted EPS miss of ~$0.01 vs consensus, but the YoY decline in adjusted EPS from $0.44 to $0.27 is significant, representing a 39% drop.

revenueepsmarginsoperating income

Risk Factors

  • Continued deterioration in constant currency sales, particularly in Americas and EMEA
  • Restructuring execution risk and potential for further impairments
  • High debt levels ($2.2B net debt) could pressure cash flows if operating performance doesn't improve
  • Competitive pressure in dental equipment and implant solutions

Market Snapshot

Exchange
Nasdaq
Sector
Dental Equipment & Supplies
Analyst Consensus
36% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000818479-26-000147
Document: dentsply8kq12026ex992.htm0000818479-26-000147
Document: xray-20260505.htm0000818479-26-000147
Document: 0000818479-26-000147-index-headers.html0000818479-26-000147
Document: 0000818479-26-000147-index.html0000818479-26-000147
Document: 0000818479-26-000147.txt0000818479-26-000147
8-K Data (Synthetic)0000818479-26-000147

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026